Finance

Beta
Lists
PHAT:NASDAQ
Phathom Pharmaceuticals Inc
၁၁.၀၉ US$
+၂.၁၂%
(+၀.၂၃) 1D
ဇွန် ၂၄, GMT-၄ ၁၁:၄၂:၃၉  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHAT...
Open
၁၀.၈၆ US$
High
၁၁.၁၆ US$
Low
၁၀.၈၅ US$
Mkt. cap
၈၈.၄၅ ကုဋေ
Avg. vol.
၁.၀၇ သန်း
Volume
၂.၁၇ သိန်း
52-wk high
၁၈.၃၁ US$
52-wk low
၇.၆၁ US$
EPS
-၂.၁၁ US$
Beta
၀.၅၀
Shares outstanding
၇.၉၈ ကုဋေ
No. of employees
၃၇၁
Open
၁၀.၈၆ US$
High
၁၁.၁၆ US$
Low
၁၀.၈၅ US$
Mkt. cap
၈၈.၄၅ ကုဋေ
Avg. vol.
၁.၀၇ သန်း
Volume
၂.၁၇ သိန်း
52-wk high
၁၈.၃၁ US$
52-wk low
၇.၆၁ US$
EPS
-၂.၁၁ US$
Beta
၀.၅၀
Shares outstanding
၇.၉၈ ကုဋေ
No. of employees
၃၇၁
News stories
From sources across the web
Investing.com Canada
Investing.com Canada
·
ပြီးခဲ့သည့် ၁ ရက်
Phathom Pharmaceuticals completes enrollment in Phase 2 EoE study By Investing.com
Investing.com Canada
Investing.com Canada
·
ပြီးခဲ့သည့် ၁ ရက်
Phathom completes enrollment in vonoprazan trial for EoE By Investing.com
About Phathom Pharmaceuticals Inc
CEO-
Employees၃၇၁
Founded၂၀၁၈
HeadquartersFlorham Park, နယူးဂျာစီပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitephathompharma.com
Analyst Ratings
Based on 6 analysts giving stock ratings to PHAT in the past 3 months
Strong Buy
Buy
5
Hold
1
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PHAT in the last 3 months.
Highest
Current ၁၁.၀၉ US$
၂၈.၀၀ US$ (+၁၅၂.၄၈%)
Average
၂၄.၂၅ US$ (+၁၁၈.၆၇%)
Lowest
၁၈.၀၀ US$ (+၆၂.၃၁%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
၂၆.၀၀ US$
+၁၃၄.၄%
06/17/2026
Joseph Stringer
Needham
Buy
Maintained
၂၈.၀၀ US$
+၁၅၂.၅%
06/01/2026
Jenna Davidner
Barclays
Buy
Maintained
၁၈.၀၀ US$
+၆၂.၃%
05/15/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
၂၅.၀၀ US$
+၁၂၅.၄%
04/30/2026
Paul Choi
Goldman Sachs
Hold
Maintained
-
-
04/30/2026
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
-
-
04/28/2026
Last report
၂၀၂၆ ဧ ၃၀
Fiscal period
Q1 2026
EPS / Est. (USD)
-၀.၁၈ US$ / -၀.၂၀ US$
+၁၁.၀၄%beat
Revenue / Est. (USD)
၅.၈၃ ကုဋေ / ၅.၇၄ ကုဋေ
+၁.၆၄%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၃.၉၅ ကုဋေ
၄.၉၅ ကုဋေ
၅.၇၆ ကုဋေ
၅.၈၃ ကုဋေ
Cost of goods sold
၅.၀၄ သန်း
၆.၁၉ သန်း
၇.၆၅ သန်း
၁.၂၀ ကုဋေ
Cost of revenue
၅.၀၄ သန်း
၆.၁၉ သန်း
၇.၆၅ သန်း
၁.၂၀ ကုဋေ
Research and development expenses
၉.၀၈ သန်း
၇.၀၃ သန်း
၇.၄၉ သန်း
၇.၇၇ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၈.၅၃ ကုဋေ
၅.၁၆ ကုဋေ
၄.၈၄ ကုဋေ
၅.၄၀ ကုဋေ
Operating expense
၉.၄၄ ကုဋေ
၅.၈၆ ကုဋေ
၅.၅၉ ကုဋေ
၆.၁၈ ကုဋေ
Total operating expenses
၉.၉၄ ကုဋေ
၆.၄၈ ကုဋေ
၆.၃၅ ကုဋေ
၇.၃၈ ကုဋေ
Operating income
-၅.၉၉ ကုဋေ
-၁.၅၃ ကုဋေ
-၅.၉၃ သန်း
-၁.၅၅ ကုဋေ
Other non operating income
-၁.၅၅ သိန်း
-၇.၀၀ ထောင်
-၅.၀၀ ထောင်
-၈.၃၁ သိန်း
EBT including unusual items
-၇.၅၈ ကုဋေ
-၃.၀၀ ကုဋေ
-၂.၁၁ ကုဋေ
-၃.၀၄ ကုဋေ
EBT excluding unusual items
-၇.၅၈ ကုဋေ
-၃.၀၀ ကုဋေ
-၂.၁၁ ကုဋေ
-၃.၀၄ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၇.၅၈ ကုဋေ
-၃.၀၀ ကုဋေ
-၂.၁၁ ကုဋေ
-၃.၀၄ ကုဋေ
Net profit margin
-၁၉၁.၉၁%
-၆၀.၅၅%
-၃၆.၇၃%
-၅၂.၀၉%
Earnings per share
-၀.၇၉
-၀.၁၅
-၀.၀၈
-၀.၁၈
Interest and investment income
၁.၇၉ သန်း
၁.၄၁ သန်း
၁.၂၀ သန်း
၁.၇၄ သန်း
Interest expense
-၁.၇၅ ကုဋေ
-၁.၆၁ ကုဋေ
-၁.၆၄ ကုဋေ
-၁.၅၈ ကုဋေ
Net interest expenses
-၁.၅၇ ကုဋေ
-၁.၄၇ ကုဋေ
-၁.၅၂ ကုဋေ
-၁.၄၁ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
-၅.၉၈ ကုဋေ
-၁.၅၁ ကုဋေ
-၅.၈၀ သန်း
-၁.၅၄ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer